112 related articles for article (PubMed ID: 3352945)
1. [Determination of fibrinogen-fibrin degradation factors in neoplasms].
Petrella V; Massara G; Parachini F; Silvera F; Cantone R
Minerva Med; 1988 Feb; 79(2):117-21. PubMed ID: 3352945
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of several parameters of coagulation in liver cirrhosis: disseminated intravascular coagulation or pseudo-disseminated intravascular coagulation?].
Petrella V; Parachini F; Rigotti T; Galimberti M; Cusumano S
Minerva Med; 1988 Mar; 79(3):193-8. PubMed ID: 3362400
[TBL] [Abstract][Full Text] [Related]
3. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
Kotajima N; Kanda T; Fukumura Y; Kobayashi I
J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
[TBL] [Abstract][Full Text] [Related]
4. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
5. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.
Sallah S; Wan JY; Nguyen NP; Hanrahan LR; Sigounas G
Thromb Haemost; 2001 Sep; 86(3):828-33. PubMed ID: 11583315
[TBL] [Abstract][Full Text] [Related]
6. Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.
Sigal SH; Cembrowski GS; Shattil SJ; Brown NM; Schifreen RS; Schwartz MW
Arch Intern Med; 1987 Oct; 147(10):1790-3. PubMed ID: 3662708
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
8. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
9. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
10. [Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
Isogai N; Yamagishi T; Kaku M; Matsumoto K; Yamamoto Y; Kuroso K; Arai M; Yorifuji H; Fukutake K; Fujimaki M
Rinsho Byori; 1991 Jul; 39(7):753-7. PubMed ID: 1920869
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
Lychev VG; Momot AP; Cherkashin GV
Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
[TBL] [Abstract][Full Text] [Related]
12. [The products of blood coagulation and fibrinolysis and their effect on pulmonary gas-exchange function].
Riabov GA; Pasechnik IN; Emtsov IuG; Azizov IuM
Ter Arkh; 1990; 62(7):95-8. PubMed ID: 2123576
[TBL] [Abstract][Full Text] [Related]
13. [Fibrinogen and fibrin degradation products in the blood of acute myocardial infarct patients at the hospital rehabilitation stage].
Solov'ev AV; Ermolin GA; Ignashenkova GV; Dikov MM
Ter Arkh; 1987; 59(10):21-3. PubMed ID: 3324376
[TBL] [Abstract][Full Text] [Related]
14. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
[TBL] [Abstract][Full Text] [Related]
15. [Fibrin degradation products (FDP) and fibrinolytic activity of blood in various acute and chronic diseases].
Kotschy M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):425-30. PubMed ID: 63429
[No Abstract] [Full Text] [Related]
16. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
17. [Differential determination of fibrinogen degradation products in assessment of the stages of plasma consumption in patients with infection and liver cirrhosis].
Raschka C; Róka L
Leber Magen Darm; 1993 Jan; 23(1):31-4. PubMed ID: 8445974
[TBL] [Abstract][Full Text] [Related]
18. Serum fibrinogen/fibrin degradation products in patients with ovarian carcinoma.
Lalos O; Frankendal B; Rudolphi O
Ann Chir Gynaecol; 1977; 66(3):131-134. PubMed ID: 327909
[TBL] [Abstract][Full Text] [Related]
19. [Coagulation tests in septic surgical patients].
Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
